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PURPOSE. To develop a culture regime for the in vitro human lens capsular bag model that
better reflects clinical events following cataract surgery and to use this refined model to
evaluate the putative impact of IOLs on PCO formation.
METHODS. Capsulorhexis and lens extraction were performed on human donor eyes to
generate capsular bags attached to the ciliary body by the zonules. Preparations were secured
by pinning the ciliary body to a silicone ring and maintaining in 6 mL serum-free EMEM for 28
days or in a graded culture system (days 1–3, 5% human serum and 10 ng/mL TGFb2; days 4–
7, 2% human serum and 1 ng/mL TGFb2; days 8–14, 1% human serum and 0.1 ng/mL TGFb2;
days 15–28, serum-free EMEM), which better mimics clinical changes. Preparations were
monitored with phase-contrast and modified-dark-field microscopy. Cell coverage and light
scatter were quantified using image analysis software. The transdifferentiation marker, a-SMA
and matrix component, fibronectin were assessed by immunocytochemistry. To assess IOLs in
the model, Alcon Acrysof or Hoya Vivinex IOLs were implanted in match-paired capsular
bags.
RESULTS. Match-paired experiments showed that graded culture enhanced growth, facilitated
matrix contraction, increased transdifferentiation, and promoted matrix deposition relative to
serum-free culture. The graded culture protocol was applied to match-paired bags implanted
with a Hoya Vivinex or an Alcon Acrysof IOL. The Vivinex demonstrated a lag in growth
across the posterior capsule. However, by day 28, coverage was similar, but light-scatter was
greater with Acrysof implanted. Cell growth on the Acrysof IOL anterior surface was
significantly greater than Vivinex.
CONCLUSIONS. The graded culture human capsular bag model serves as an excellent system to
evaluate and develop intraocular lenses. The Hoya Vivinex IOL showed an overall better level
of performance against postsurgical wound healing and PCO than the Alcon Acrysof using
this model.
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In the majority of cases, cataract is a consequence of the agingof the lens and is the major priority in the global initiative to
eliminate avoidable blindness by the year 2020.1 At present, the
only means of treating cataract is by surgical intervention, and
this initially restores high visual quality. Unfortunately, posterior
capsule opacification (PCO), the most common complication of
cataract surgery, develops in millions of patients worldwide to
such an extent that a secondary loss of vision occurs.2
The intraocular lens (IOL) is an important component
within cataract surgery; in addition to restoring refractive
power, it can also affect the progression of PCO.2–7 At present it
is widely believed that an IOL with a square-edge profile and
complete contact between the IOL and the capsulorhexis offers
the best PCO prevention. Preclinical testing of IOLs most
commonly employs the rabbit due to the similar dimensions of
the human and rabbit lenses. While the rabbit provides an in
vivo test system, postsurgical responses are severe, the
experimental period is usually months, and the factors driving
PCO will differ from human.7,8 Evaluation of IOLs can also be
performed using human capsular bag models. These systems
have served as a valuable tool to understand the biologic
processes governing PCO and have been used to evaluate
clinical products including IOLs.9 To enhance the utility of the
capsular bag model for evaluation and development of IOLs, the
model has evolved with time and incremental improvements
have been made. The first iteration secured (anterior face up)
the capsular bag containing an IOL to a dish using entomolog-
ical pins at the equator.10 While this was useful for assessing the
use of the IOL as a drug delivery system,11 it failed to allow
interaction between the IOL and capsule as seen in patients. To
improve interaction between the IOL and capsule a modifica-
tion was introduced, such that the bag was secured to the dish
with the anterior capsule down.12 When the periphery was
secured, this led to good interaction between the optic edge
and the capsule. Further modifications were made that replaced
fetal calf serum with human serum and the application of TGFb
was also introduced to further mimic biologic events associated
with PCO in humans.12 Cleary et al.13 adapted the model to
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maintain integrity of the capsular bag. To achieve this, the
ciliary body was retained in addition to the capsular bag
generated from simulated cataract surgery. The ciliary body is
secured to a silicone ring, which allows the bag containing an
IOL to be suspended by the zonules over the lumen of the ring.
This allows a natural interaction between the IOL and capsular
bag to occur. Using this system, IOLs have been previously
assessed,3 but conditions involved either serum-free or human
serum supplemented medium as the maintenance medium for
the experimental duration.3 However, the previous models did
not reflect the clinical observations for patients, where the
elevation of proteins in the aqueous humor following surgery is
transient, such that levels peak in the first week then decline to
baseline.14 With this in mind, our approach in this current
study was to employ culture conditions that better reflect this
general pattern of response and validate that such conditions
could mimic features previously reported in postmortem
capsular bag samples.15 This was achieved by establishing a
culture protocol based on clinical data14 that has shown
increased levels of protein in the eye (detected by flare
measurements) following surgery that peak within the first
week and then decline to baseline levels. Similarly, TGFb levels
are believed to rise following surgery and we assume this
elevation will also be transient.2,16 We describe the conditions
that employ transient elevation of serum and TGFb in this
study as a graded culture system. Using graded culture
conditions, it is possible to use this modified and improved
model to assess the relative ‘‘barrier’’ function of IOLs,
progression of cell cover within the visual axis (on the
posterior capsule and IOL), light scatter, and cell behavior
following reduction/removal of exogenously applied serum/
TGFb. All these features contribute to PCO and thus can help
better predict the potential clinical performance of IOLs.
METHODS
Capsular Bag Preparation
The model previously described by Liu et al.,10 developed by
Cleary et al.13 and further refined by Eldred et al.3 was
employed with additional refinements. Donor human eye
globes were obtained with UK National Research Ethics
Committee approval (REC 04/Q0102/57) and used in accor-
dance with the tenets of the Declaration of Helsinki. A small
capsulorhexis was introduced on the anterior surface of the
lens capsule, and the central fibrous mass was removed via
hydrodissection, revealing the capsular bag. In some cases, an
IOL (Hoya Vivinex or Alcon Acrysof) was implanted. The
capsular bag (with or without an IOL implanted) and a ring of
ciliary tissue secured to a silicone ring was transferred to a
tissue culture dish. This arrangement allows capsular bags to
suspend from the zonules, and were maintained in defined
culture conditions over 28 days. To better reflect the clinical
changes to the lens environment post-surgery,14,16 the defined
culture system was initiated with elevated protein (serum and
TGFb) levels that were gradually reduced to a serum-free
environment, as follows: days 1 to 3, 5% human serum and 10
ng/mL TGFb2; days 4 to 7, 2% human serum and 1 ng/mL
TGFb2; days 8 to 14, 1% human serum and 0.1 ng/mL TGFb2;
days 15 to 28, serum-free EMEM. Two series of match-paired
experiments were performed in the current study. The first
series was to establish the graded-culture system, such that
match-paired experiments were performed using two lenses
from the same donor, where one preparation was treated with
graded culture while the partner capsular bag was maintained
in untreated serum-free control medium. The second match-
paired series was used to evaluate two IOLs using the graded-
culture system, the match-paired experiments were carried out
using two lenses from the same donor both maintained in the
graded culture system, where one capsular bag was implanted
with an Alcon Acrysof IOL and its partner was implanted with
a Hoya Vivinex IOL. Cell coverage of the previously cell-free
posterior capsule, and additional surfaces such as the IOL,
were captured using low-power phase microscopy. The level
of cell cover on the posterior capsule (PC), within the visual
axis, was quantified from micrographs using ImageJ analysis
software (http://imagej.nih.gov/ij/; provided in the public
domain by the National Institutes of Health, Bethesda, MD,
USA). To achieve this, low-power dark-field images of capsular
bags, with IOLs removed, were captured at endpoint and
analyzed, such that the central visual axis (outlined by the
capsulorhexis) was defined and its area quantified. The areas
within this region of interest covered by cells was manually
defined and the area of all cell covered regions quantified. The
area of cell covered regions was then expressed as a
percentage of the central visual axis area.
Quantification of Light Scatter
Modifications to the posterior capsule cause light scatter and
are significant contributors to visual disturbance associated
with PCO. To establish a measure of light scatter in the central
PC, Image Pro Premier software (Media Cybernetics, Warren-
dale, PA, USA) was employed using a published method
adapted from Wormstone et al.17 In the present study, modified
dark-field images of the central posterior capsule, obtained
following IOL removal, were placed through a single pass of a
Laplacian filter, which identifies light scattering regions. These
regions appear bright, and thus have a high intensity per pixel
relative to nonscattering regions. The standard deviation of the
pixel intensities within the rhexis region was determined.
Capsular bags without cells present on the PC were used to
establish background levels, which was subtracted from test
values.
Immunocytochemistry
Transdifferentiation of epithelial cells to myofibroblasts and
deposition of the matrix component fibronectin are clinical
features of PCO. We, therefore, employed immunocytochem-
istry to visualize and quantify expression of the myofibroblast
marker, a-SMA, and fibronectin. All reagents were from Sigma-
Aldrich (Poole, Dorset, UK) unless otherwise stated. Washes
were for 3 3 15 minutes in PBS. IOLs were removed from
capsular bag preparations then fixed for 30 minutes in 4%
formaldehyde in PBS and permeabilized in PBS containing 0.5%
Triton-X100, also for 30 minutes. Nonspecific sites were
blocked with normal goat serum (1:50 in 1% BSA/PBS). Anti-
alpha smooth muscle actin or anti-fibronectin was diluted
1:100 in 1% BSA/PBS and applied for 60 minutes at 358C,
followed by washing. Alpha smooth muscle actin and
fibronectin presence was visualized with AlexaFluor 488–
conjugated secondary antibodies (Molecular Probes, Leiden,
The Netherlands). The stained preparations were again washed
extensively, floated onto microscope slides, and mounted in
mounting medium (Hydromount; National Diagnostics, Hull,
UK). Images were viewed with a epifluorescence microscope
and software (Axiovision; Carl Zeiss AG, Oberkochen, Ger-
many).
Measuring Cell Cover on the Posterior and
Anterior Surfaces of the IOL
At endpoint, IOLs were carefully removed from the capsular
bag prior to fixation by creating radial incisions close to the
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haptic arms. This allowed the haptics to be held by fine forceps
and the IOL to be carefully removed from the capsular bag with
minimal disruption to cell populations. The IOL was then
immediately placed in fixative (4% formaldehyde) for 30
minutes followed by washing in PBS. The IOL was then placed
in Coomassie Brilliant Blue for 1 hour. Following this period,
the IOLs were washed multiple times in PBS to remove excess
dye. The stained IOLs were imaged using bright-field illumina-
tion and a charge-coupled device (CCD) camera (UVP, Cam-
bridge, UK) with Synoptics software (Synoptics, Cambridge,
UK). The amount of cell coverage was determined using
ImageJ 1.45s image analysis software.
FIGURE 1. Assessment of growth characteristics and matrix modification in capsular bags maintained under graded culture (days 1–3, 5% human
serum and 10 ng/mL TGFb2; days 4–7, 2% human serum and 1 ng/mL TGFb2; days 8–14, 1% human serum and 0.1 ng/mL TGFb2; days 15–28 serum-
free) or serum-free (SF) culture conditions. (A) Progressive movement of cells (leading edge indicated by white arrows), initially on the peripheral
posterior capsule (day 7), then beyond the rhexis margin (black arrows) onto the central posterior capsule (days 14, 21 and 28). Note that
wrinkling of the posterior capsule is associated with movement in graded cultures, whereas serum-free cultures exhibit matrix wrinkling once
movement has been arrested. (B) Quantitative analysis showing cell coverage of the central posterior capsule (within the rhexis margin) in serum-
free and graded culture conditions. Data are presented as mean 6 SD (n¼ 5). *Indicates a significant difference between groups (Student’s t-test; P
 0.05). (C) Pooled data showing light scatter of the central PC in capsular bags that had been cultured for 28 days in serum-free or graded culture
conditions. Data are presented as mean 6 SD (n¼ 5). *Indicates a significant difference between groups (Student’s t-test; P  0.05).
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RESULTS
Establishing a Graded Culture Capsular Bag Model
Through application of the graded culture protocol, it was
predicted that the presence of serum would stimulate growth
and TGFb would promote EMT, matrix deposition, and matrix
contraction (capsule wrinkling), which are all clinical features
of PCO.2 Match-paired experiments were established from five
donors (range: 42–82 years; mean age: 60.2 6 15.9 years; 1
male and 4 female) with one donor used for each match-paired
experiment. It was evident within the first week of culture that
cells had recolonized denuded regions of the anterior capsule
and had started to migrate across the posterior capsule beneath
the overlying anterior capsule in graded culture and serum-free
control conditions (Fig. 1A). At day 14, cells had progressed
beyond the rhexis margin and entered the central visual axis
(Fig. 1A). Cells continued to cover the posterior capsule for the
remaining culture period, but the rate of progression was
significantly greater with graded culture conditions (Figs. 1A,
1B). It was also evident in the graded culture preparations that
matrix contraction occurred as cells covered the posterior
capsule, whereas serum-free cultures migrated as a sheet of
cells and only induced matrix contraction when movement
had ceased (Fig. 1A). Overall, match-paired comparison
revealed a significant difference in light scatter between the
graded culture and serum-free control treatments (Fig. 1C). At
the endpoint of 28 days, preparations were fixed and assessed
for the matrix component, fibronectin, and the myofibroblast
marker, a-smooth muscle actin. It was found that both
fibronectin and a-smooth muscle actin were significantly
increased with graded culture relative to serum-free control
(Fig. 2). The graded culture regime applied to capsular bags;
therefore, enhanced growth, promoted matrix contraction,
increased EMT markers, and promoted matrix deposition.
These features reflect previously reported post-mortem anal-
ysis15 and thus suggest the capsular bag model maintained in
graded culture conditions is a suitable model to evaluate the
ability of different IOLs to moderate PCO following implanta-
tion during cataract surgery. In the present study, we compared
Alcon Acrysof and Hoya Vivinex IOLs using this test system.
FIGURE 2. (A) Representative epifluorescence micrographs showing the distribution of the myofibroblast marker, a-smooth muscle actin and the
matrix component, fibronectin associated with cells growing on the central posterior capsule of human lens capsular bag preparations maintained
in SF or graded culture conditions. Images were captured at endpoint (day 28). (B) Pooled data showing quantitative aSMA and fibronectin
expression in association with cells growing on the central PC of capsular bags maintained in serum-free or graded culture conditions. Data are
presented as mean 6 SD (n ¼ 5). *Indicates a significant difference between groups (Student’s t-test; P  0.05).
FIGURE 3. Representative modified dark-field images of match-paired
capsular bags implanted with a Hoya Vivinex or an Alcon Acrysof IOL
captured on the day of simulated surgery. In both cases the
capsulorhexis (arrowed) is fully seated on the IOL optic.
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IOL Evaluation Using the Graded Culture Capsular
Bag Model
Twelve eyes from six donors (range 50–84 years; mean age 70 6
10.3 years; 2 male and 4 female) with one donor used for each
match-paired experiment in this study. There was no discernible
difference in the ease of implantation between the Hoya Vivinex
and Alcon Acrysof IOLs. Similar sized capsulorhexes (4.5–5 mm
diameters) were generated and in all cases the capsulorhexis
was completely mounted on the anterior IOL optic face (Fig. 3).
FIGURE 4. Observation of cell growth progression on the posterior capsule in capsular bag preparations implanted with a Hoya Vivinex or Alcon
Acrysof IOL. The data represent observations from six match-paired capsular bag preparations. A schematic shows the peripheral edge region
(green) and central visual axis region (red) of the IOL (A). The number of IOLs with cell presence on the peripheral edge (B) and the central visual
axis (C) were quantified, in which both analysis showed that Hoya Vivinex IOLs have reduced presence of cells at day 14 compared to Alcon Acrysof
IOLs.
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Residual populations of lens epithelial cells on the anterior lens
epithelium following simulated cataract surgery was comparable
between each capsular bag preparation from a single donor
(data not shown).
Cell Growth on the Posterior Capsule
Within the first few days following simulated surgery and IOL
implantation, recolonization of denuded regions of the anterior
capsule could be seen with either IOL present. Within the first
week of culture no cells were observed on the posterior
capsule underneath the IOL optic (i.e., the IOL square-edge
barrier had not been breached; Fig. 4). As time progressed cells
could be seen growing on the peripheral posterior capsule
(beneath the anterior capsule; Fig. 5). In general, the rate of
this coverage was to be slower with the Hoya Vivinex IOLs
implanted compared to preparations implanted with an Alcon
Acrysof IOL. This is illustrated by Figure 5, which shows
growth of cells on the central posterior capsule (beyond the
rhexis) at day 11 with an Acrysof IOL implanted, whereas the
Hoya Vivinex implanted match-paired preparation presented
cells past the IOL edge, but had not progressed beyond the
rhexis edge at day 13 (Fig. 5). Following 2 weeks of culture, a
number of preparations exhibited some cell growth on the
posterior capsule beneath the IOL demonstrated that the IOL
square-edge barrier had been breached (five out of six Vivinex
versus six out of six Acrysof; Fig. 4). This difference was more
pronounced when the central posterior capsule (PC), within
the rhexis margin (which directly correlates to the central
visual axis), was assessed. Three out of six Hoya Vivinex IOLs
implanted preparations showed cells detectable within this
region, while 6 out of 6 Alcon Acrysof IOLs implanted
preparations had cells within the central visual axis (Figs. 4,
5). As the culture period was extended, cells continued to
populate the posterior capsule as expected. At the endpoint of
28 days, all preparations exhibited some cell growth within the
rhexis margin (Figs. 4, 6). Cell coverage within the rhexis
margin (central visual axis) was not significantly different, such
that the level of cover was quantified at 34.4% 6 25.4% and
37.4% 6 27.7% for Hoya Vivinex IOLs and Alcon Acrysof IOLs
respectively (Fig. 6B). It should also be noted that matrix
contraction on the central PC (central visual axis) was
observed in most cases when cell growth in this region was
seen. However, the degree of light scatter detectable in the
central visual axis was significantly greater with Alcon Acrysof
IOLs implanted relative to the Hoya Vivinex IOLs (Fig. 6C).
While the degree of light scatter varied from donor to donor, it
should be noted that detected light scatter was consistently
lower with Hoya Vivinex IOLs in all six match-paired
experiments with statistical significance measured at P  0.05.
Cell Coverage on the IOL Anterior Surface
On the anterior face of the IOL, significantly more cell coverage
was observed with Alcon Acrysof IOL implanted capsular bags
than preparations implanted with a Hoya Vivinex IOL. While
the degree of outgrowth onto the IOLs varied from donor to
donor, the pattern of response was consistent in all six of the
match-paired experiments (Fig. 7).
Within the first week of culture, in two out of six cases,
cells were seen attached to the IOL, growing from the rhexis
edge on to the Alcon Acrysof IOL anterior surface (Fig. 7A). No
growth onto the IOL was observed at this stage when a Hoya
Vivinex IOL was implanted. By day 14, four out of six Hoya
Vivinex IOLs had observable cell outgrowth compared to five
out of six Alcon Acrysof IOLs (Fig. 7A). This pattern was
maintained until the final week of culture and at endpoint all
12 IOLs implanted exhibited some degree of coverage within
the rhexis margin (Fig. 7B). The amount of cell coverage was
significantly greater on Alcon Acrysof IOLs than their Hoya
Vivinex counterparts (Figs. 7B, 7C). The reduced cell
outgrowth on the Hoya Vivinex IOL anterior surface implies
better optical performance due to a clearer light path through
the IOL, which reduces cell-induced light scattering or glare.18
DISCUSSION
Refinement of the Capsular Bag Model for IOL
Evaluation
It was clear from match-paired experiments that our graded
culture conditions reflected clinical events associated with
PCO, such that cell growth (proliferation/migration), matrix
deposition, matrix contraction, and EMT were significantly
enhanced relative to serum-free controls. Adopting this
strategy reflects the general pattern of the postsurgical
environment, such that there is a transient increase in putative
exogenous stimuli followed by extended periods when the
supply of exogenous stimuli is minimal. At this stage,
progression is driven by lens cells and their interaction with
FIGURE 5. Representative phase-contrast micrographs showing progressive cell growth on the posterior capsule of match-paired capsular bags
implanted with a Hoya Vivinex or Alcon Acrysof IOL. The capsulorhexis edge is highlighted by white asterisks. And the IOL optic perimeter is
highlighted by white arrows.
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FIGURE 6. (A) Representative modified dark-field and phase-contrast images of capsular bags, captured prior to fixation, at the 28-day endpoint. (B)
Pooled data showing coverage of the central PC by LECs, at the end of 28 days, in the presence of Hoya Vivinex or an Alcon Acrysof IOL. Data are
presented as mean 6 SD (n¼ 6). No significant difference was observed between groups (Student’s t-test; P  0.05). (C) Pooled data showing light
scatter of the central PC in capsular bags that had been cultured for 28 days in the presence of Hoya Vivinex or an Alcon Acrysof IOL. Data are
presented as mean 6 SD (n ¼ 6). *Indicates a significant difference between groups (Student’s t-test; P  0.05).
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the lens capsule. It is known that a number of growth factors,
such as FGF, HGF and VEGF can promote wound healing
leading to PCO following cataract surgery.2,9 Many of these
factors become elevated in the eye following a breakdown of
the blood aqueous barrier and thus addition of serum to our
cultures mimics this process. TGFb2 is the major TGFb isoform
within the eye and following surgery, activation will be
increased in addition to greater production by ocular tissues.16
As the increase in TGFb2 within the eye is fundamentally a
local event, TGFb2 was added in addition to serum, so that
both postsurgical changes could be modelled. The levels of
serum and TGFb used in the current model will represent a
fairly extreme postsurgical response, but this affords the
opportunity to provide a greater challenge to IOLs in relation
to anti-PCO performance. Using our graded culture system, the
initial drive from added serum allows the barrier function of
the IOL to be tested. In addition, we can assess cell
progression, light scatter and cell behavior as PCO is forming
over time, rather than an endpoint measurement seen in rabbit
studies and human clinical data. In the first instance, we
elected to compare IOLs used in a large number of patients,
which are hydrophobic acrylic lenses sold by market leaders:
the Hoya Vivinex and the Alcon Acrysof. Both designs
incorporate a square-edge optic feature to inhibit PCO.
The Effect of IOLs on Cell Growth and Modification
of the Anterior and Posterior Capsule
The Hoya Vivinex IOL demonstrated a lag in cell growth across
the posterior capsule following simulated cataract surgery
relative to the Alcon Acrysof IOL. However, by day 28
(endpoint) the degree of coverage was similar, but the level
of light scattering elements in the central visual axis was
consistently greater with an Alcon Acrysof implanted than a
Hoya Vivinex. Overall, it would appear that progression
through different phases of PCO is retarded to some degree
with the Hoya Vivinex IOL relative to Alcon Acrysof. These
differences first seem apparent with progression of cells from
the equatorial region onto the posterior capsule. This trend
cannot be attributed to differences in the remaining anterior
epithelium as remaining populations were comparable in both
preparations from an individual donor. It is therefore likely that
a design feature of the Hoya Vivinex IOL affords some
biological benefit. The cells growing on the posterior capsule
of Alcon Acrysof implanted bags typically encounter the IOL
edge more rapidly than with Hoya Vivinex and movement
beyond the square-edge is again more likely to occur with an
Acrysof IOL implanted. The square-edge barrier afforded by the
Hoya Vivinex does not appear to offer any more or less
impedance to cell movement than the Alcon Acrysof counter-
part. This suggests that square-edge barrier alone may not be
sufficient to prevent PCO. With time a general pattern of cover
on the central PC is established that is similar in both cases, but
matrix contraction is significantly more advanced with Alcon
FIGURE 7. (A) Observation of cell outgrowth on the anterior IOL
surface (central visual axis) in capsular bag preparations implanted
with a Hoya Vivinex or Alcon Acrysof IOL. The data represent
observations from 6 match-paired capsular bag experiments. At day 7,
Hoya Vivinex samples do not show any cell growth on the anterior IOL
surface (central visual axis). (B) Representative bright-field images
showing cell coverage on Hoya Vivinex and Alcon Acrysof IOLs
isolated from capsular bags at endpoint (28 days) and stained with
Coomassie brilliant blue. (C) Pooled data showing coverage of the
anterior IOL surface of Hoya Vivinex and Alcon Acrysof IOLs isolated
from capsular bag preparations at endpoint (28 days). Data are
presented as mean 6 SD (n ¼ 6). *Indicates a significant difference
between groups (Student’s t-test; P  0.05).
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Acrysof IOLs implanted. It would therefore seem that the Hoya
Vivinex IOL tempers the first phase of cell growth immediately
following surgery, which ultimately reflects a retardation of
PCO changes over time relative to the Alcon Acrysof.
Cell Growth on the IOL
The ability of cells to grow on the anterior surface of both IOLs
implanted was observed over the period of study. However,
cells were more likely to migrate onto the Alcon Acrysof IOL
than the Hoya Vivinex. To this effect, the first observations of
cell growth on the Alcon Acrysof preceded those observed on
the corresponding match-paired Vivinex IOL. Moreover, the
extent of growth on the IOL was significantly more pro-
nounced with an Alcon Acrysof IOL implanted than the Hoya
Vivinex. This is an important feature as it has been previously
reported that cells present on the IOL surface can cause light
scatter18 and thus contribute to visual deterioration following
cataract surgery.
Previous reports have proposed that lens cells and capsule
can establish an interaction with the IOL that influences its
physical properties.19,20 This has been implied for both the
Alcon Acrysof and the Hoya Vivinex. In the latter case it has
been suggested that UV/Ozone treatment of the posterior IOL
surface increases interaction with cells using fibronectin as a
biological glue.21 The data obtained in our study suggests that
interaction between lens cells and either of the IOLs tested is
limited. When the cells have a choice of capsule or an IOL
material they preferentially choose lens capsule as the native
capsule provides complex biological signals that modulate cell
behavior compared to a bioinert synthetic surface. Conse-
quently, the major site of cell attachment on the IOLs studied
was on the anterior surface of the optic within the central
visual axis.
Future Developments
While a valuable tool for lens and IOL research, the newly
described graded culture capsular bag model still possesses
some limitations and has scope for further development.
Elschnig’s pearl and Soemmering’s ring formation are not
observed in the model.8 Therefore, the results reported here
present a fibrotic PCO model. Elschnig’s pearls and Soemmer-
ing’s ring typically develop at later stages in PCO development,
and are generally believed to be associated with regenerative
PCO. Future studies will aim to develop culture regimes to
promote regenerative PCO within the capsular bag model. The
model is also limited to some degree by the availability of
tissue, but the opportunity to perform match-paired experi-
ments greatly increases experimental power as two lenses
from a single donor respond in a similar manner.22 The graded
culture regime utilized relatively high serum and TGFb levels to
initially drive the system followed by a gradual reduction and
ultimately a return to serum free conditions. This allows key
measures to be obtained in a limited experimental period, (i.e.,
4 weeks), which permits more rapid feedback and will inform
and facilitate IOL development more efficiently. The rate of
change associated with the current graded culture regime is
most likely to be greater in the model than in patients. As a
result, the observed differences in the model could serve as a
predictive tool of the relative rate and severity of PCO that may
occur in a patient with different IOLs implanted during
cataract surgery. The serum and TGFb levels of the model
could, be adapted further when clinical data of serum and
TGFb levels in patient are collected, and the culture period
could be extended depending on the objective of the assay to
measure a true time-progression or accelerated PCO model.
Using this approach, a graded culture system to measure PCO
formation will complement current research using clinical data
and in vivo rabbit models.
Summary
The graded culture human capsular bag model reflects the
pattern of postsurgical changes in the ocular environment and
gives rise to clinical features of PCO. The truncated timeframe
of 1 month (28 days cell culture) enables IOLs to be assessed
for PCO formation tendency, as opposed to implanting the
IOLs in a rabbit model in which PCO is aggressive or to
implanting the IOLs in human patients and waiting for
postmortem assessment of PCO performance. It therefore
serves as an excellent system to evaluate and develop
intraocular lenses. Using this system, it was found that the
Hoya Vivinex IOL showed an overall better level of perfor-
mance than the Alcon Acrysof IOL, such that progression of
PCO appears to be slower. In addition, cells are less likely to
populate the IOL surface of the Hoya Vivinex IOL than the
Alcon Acrysof IOL, which will further reduce light scatter
following surgery.
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